Leukemia Research
Volume 26, Issue 11 , Pages 1007-1010 , November 2002

Increased serum levels of vascular endothelial growth factor correlate with splenomegaly in polycythemia vera

  • P Murphy
    • ,
  • N Ahmed
    • ,
  • H.T Hassan

      Affiliations

    • Corresponding Author InformationCorresponding author. Present address: Institute for Health, University of Lincoln, Brayford Pool, Lincoln LN6 7TS, UK. Tel.: +44-1522-886851; fax: +44-1522-886791.

Received 28 January 2002 ,Accepted 11 February 2002.

References 

  1. Weidner N, Flokman J. Tumor vascularity as a prognostic factor in cancer. In: de Vita VT, Hellman S, Rosenberg SA, editors. Important advances in oncology. Philadelphia: Lippincott–Raven, 1997. p. 167–90.
  2. Folkman J. Tumot angiogensis. In: Mendelson J, Howley MJ, Isreal MA, Liotta LA, editors. The molecular basis of cancer. Philadelphia: Saunders, 1995. p. 206–32.
  3. Vacca A, Ribatti D, Presta M, Minischetti M, Iurlaro M, Ria R, et al.  Bone marrow neovacularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood. 1999;93:3064–3073
  4. Perez-Atayde AR, Sallan SR, Tredow U, Connors S, Allred E, Folkman J. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukaemia. Ann. J. Pathol. 1997;3:815–821
  5. Farrara N, Davis-Smyth T. Biology of vascular endothelial growth factor. Endocr. Rev. 1997;18:4–25
  6. Molica S, Vitelli G, Levato D, Gandolfo GM, Liso V. Increased serum levels of vascular endothelial growth factor predict risk of progression in B-cell lymphocytic leukaemia. Br. J. Haematol. 1999;107:605–610
  7. Aguayo A, Estey E, Kantarjian H, et al.  Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukaemia. Blood. 1999;94:3717–3721
  8. Salven P, Teerenhovi L, Joensuu H. A high pre-treatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin’s lymphoma. Blood. 1997;90:3167–3172
  9. Lunberg LG, Lerner R, Sundelin P, Rogers R, Folkman J, Palmblad J. Bone marrow in polycythemia vera, CML and myelofibrosis has an increased vascularity. Am. J. Pathol. 2000;157:15–19
  10. Di Raimondo F, Azzaro MP, Palumbo GA, et al. Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis. Leukemia 2001;15:976–80.
  11. Lahtinen R, Lahtinen T, Hyodynmaa S. Increased bone marrow blood flow in polycythemia vera. Eur. J. Nuc. Med. 1983;8:19–22
  12. Berlin NI. Diagnosis and classification of the polycythemias. Sem. Hematol. 1975;12:339–351
  13. George ML, Eccles SA, Tutton MG, Abulafi AM, Swift RI. Correlation between plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?. Clin. Cancer Res. 2000;6:3147–3152
  14. Messinezy M, Westwood NB, Woodcock SP, et al.  Low serum erythropoietin—a strong diagnostic criterion of primary polycythemia even at normal haemoglobin levels. Clin. Lab. Haematol. 1995;17:217–221
  15. Mesa RA, Hanson CA, Rajkumar SV, Schroeder G, Tefferi A. Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia. Blood. 2000;96:3374–3380
  16. Zhang B, Lweis SM. The splenomegaly of myeloproliferative and lymphoproliferative disorders: splenic cellularity and vascularity. Eur. J. Haematol. 1989;43:63–66
  17. Andreasson B, Swollin B, Kutti J. Hydroxyurea treatment reduces haematopoietic progenitor growth and CD34 positive cells in polycythemia vera and essential thrombocythemia. Eur. J. Haematol. 2000;64:188–193
  18. Castello G, Lezra R, Cerruti A, Cavallini D, Bogliolo G, Pannacciulli I. Circulating haematopoietic progenitor cells in polycythemia vera: the in vivo effect of hydroxyurea. Ann. Hematol. 1995;71:119–121
  19. Andreasson B, Carneskog J, Lindsteadt G, et al.  Plasma erythropoietin concentrations in polycythemia vera with special reference to myelosuppressive therapy. Leuk. Lymphoma. 2000;37:189–195

PII: S0145-2126(02)00053-X

Leukemia Research
Volume 26, Issue 11 , Pages 1007-1010 , November 2002

Article Tools